Stay updated with breaking news from Decipher Genomics Resource. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Researchers have found that genomic risk distribution can vary widely across clinical stage groups among patients with prostate cancer. Researchers have found that genomic risk distribution can vary widely across clinical stage groups among patients with prostate cancer.
Studies presented at SUO 2023 have shed new light on risk stratification and novel treatments in prostate cancer. Studies presented at SUO 2023 have shed new light on risk stratification and novel treatments in prostate cancer.
Researchers have found that genomic risk distribution can vary widely across clinical stage groups among patients with prostate cancer. Researchers have found that genomic risk distribution can vary widely across clinical stage groups among patients with prostate cancer.
The research was aided by the Decipher Genomics Resource for Intelligent Discovery, which helped derive the gene signatures used during the analysis.
New data are from a retrospective analysis of the Phase 2 STREAM trial ...